Healthequity Inc
NASDAQ:HQY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (25.7), the stock would be worth $138.25 (70% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15.2 | $81.48 |
0%
|
| 3-Year Average | 25.7 | $138.25 |
+70%
|
| 5-Year Average | 27.3 | $146.7 |
+80%
|
| Industry Average | 16.1 | $86.39 |
+6%
|
| Country Average | 13.3 | $71.72 |
-12%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.9B USD | 15.2 | 32.2 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
336.5B USD | 0 | 27.9 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
96B USD | 0 | 18.3 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
81.9B USD | 0 | 15.6 | |
| US |
|
Humana Inc
NYSE:HUM
|
29.3B USD | 0 | 24.7 | |
| US |
|
Centene Corp
NYSE:CNC
|
26.5B USD | 0 | -4 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
10.2B USD | 28.6 | 54.3 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 13.8 | 8.5 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
8B BRL | 13.6 | 13.8 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 7.2 | 25.8 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1.4B USD | -20 | -15.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Healthequity Inc
Glance View
In the world of healthcare finance, Healthequity Inc. plays a vital role as a bridge between individuals and their healthcare savings. Founded in 2002 and headquartered in Draper, Utah, the company specializes in administering Health Savings Accounts (HSAs) and other consumer-directed benefits. By empowering more than 12 million members to make informed healthcare spending decisions, Healthequity stands at the intersection of finance and healthcare. With an impressive technological backbone, it provides seamless integration solutions for employers, health plans, and financial institutions, ensuring that account holders have easy access to their funds and efficient management tools. This integration allows individuals to save for future medical expenses tax-free, a compelling proposition as healthcare costs continue to rise. Healthequity's revenue generation is primarily tied to administrative fees and the interest income from the funds in the accounts it oversees. By offering custodial services for HSAs, Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRAs), and other benefit plans, it retains a steady stream of service fees from both employers and account holders. Furthermore, Healthequity generates revenue through partnerships with employers and insurance firms, who often incentivize HSA adoption as part of their employee health benefits packages. By capitalizing on its technological prowess and customer-centric approach, Healthequity fosters a robust growth model that capitalizes on the evolving nexus of healthcare and financial planning.